Navigation Links
Post-treatment PET scans can reassure cervical cancer patients
Date:11/20/2007

St. Louis, Nov. 20, 2007 Whole-body PET (positron emission tomography) scans done three months after completion of cervical cancer therapy can ensure that patients are disease-free or warn that further interventions are needed, according to a study at Washington University School of Medicine in St. Louis.

"This is the first time we can say that we have a reliable test to follow cervical cancer patients after therapy," says Julie K. Schwarz, M.D., Ph.D., a Barnes-Jewish Hospital resident in the Department of Radiation Oncology. "We ask them to come back for a follow-up visit about three months after treatment is finished, and we perform a PET scan. If the scan shows a complete response to treatment, we can say with confidence that they are going to do extremely well. That's really powerful."

Schwarz and colleagues published their study in the Nov. 21, 2007 issue of the Journal of the American Medical Association (JAMA).

Without a test like PET, it can be difficult to tell whether treatment has eliminated cervical tumors, Schwarz says. That's because small tumors are hard to detect with pelvic exams, and overt symptoms, such as leg swelling, don't occur until tumors grow quite large. Furthermore, CT and MRI scans often don't differentiate tumor tissue from surrounding tissues, Pap tests can be inaccurate because of tissue changes induced by radiation therapy, and no blood test exists to detect the presence of cervical cancer.

Cancerous tumors glow brightly in the PET scans used in the study, called FDG-PET scans, which detect emissions from radioactively tagged blood sugar, or glucose. Tumor tissue traps more of the glucose than does normal tissue, making tumors readily discernable.

Not only can post-treatment PET scans reassure those patients whose tumors respond well to therapy, they can also identify those patients whose tumors have not responded so that their physicians can explore other treatment options before the cancer advances further. These options can include surgery to remove tissue, standard chemotherapy or experimental therapies available through clinical trials.

"Follow-up PET scans can also be very useful tools for physicians conducting clinical trials of new therapies," Schwarz says. "Our study has shown that the scans are predictive of long-term survival. Using PET scans, clinical researchers can get an early readout of how effective experimental treatments might be."

Schwarz and colleagues also have a project to compare follow-up PET results with tumor biology to find out why some tumors don't respond well to therapy. In a study that won her a Resident Clinical Basic Science Research Award from the American Society for Therapeutic Radiation and Oncology, a global organization of medical professionals, Schwarz found differences in gene activity between tumors from patients that responded well and those that had persistent disease. Ongoing research will look for the significance of these differences.

The study's senior author, Perry Grigsby, M.D., professor of radiation oncology, of nuclear medicine and of obstetrics and gynecology and a radiation oncologist with the Siteman Cancer Center at Washington University School of Medicine and Barnes-Jewish Hospital, has overseen a patient database that now has PET images and tumor samples from hundreds of cervical cancer patients.

"We have a tremendous database of PET images collected from patients in the department since 1998," Schwarz says. "We want to combine these results with analyses of tumor biopsies so that we can more effectively choose additional therapies for patients who haven't responded to the initial treatment."


'/>"/>

Contact: Gwen Ericson
ericsong@wustl.edu
314-286-0141
Washington University in St. Louis
Source:Eurekalert

Related medicine news :

1. European directive will halt use of MRI scans; cancer diagnosis and treatment will suffer
2. PET scans can accurately detect a breast tumors response to chemotherapy
3. High-tech CT scans: not a bad choice to test for clogged arteries
4. New Computerized Scans Effective for Spotting Clogged Arteries
5. PET scans useful for some cancer treatment, but how do patients fare?
6. PET Scans Can Spot Cervical Cancers Return
7. Cervical cancer screening: Too many are left unprotected
8. Couples more likely to divorce if spouse develops cervical or testicular cancer
9. Gene-Based Screen Spots Cervical Cancer Earlier
10. Transcutaneous cervical esophageal ultrasound can not substitute for 24-h pH monitoring or manometry
11. Advaxis, Inc. phase I/II results of lovaxin C in cervical cancer study released
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... ... Tuesday, March 28, 2017, is the annual American Diabetes Association Alert Day, ... find out if they are at risk for developing Type 2 diabetes. In recognition ... by programming the LAX pylons the color red. Downtown’s U.S. Bank Tower Crown Lights ...
(Date:3/28/2017)... , ... March 28, 2017 , ... ... is pleased to be invited to the Siemens Healthineers annual customer education symposium, ... The event will take place from March 27 - 31, 2017 at the ...
(Date:3/28/2017)... ... 28, 2017 , ... City trips have soared 82% since ... Report). As travelers visit both urban destinations, they are faced with exploration that ... In response, the outdoor industry has blurred the lines between fashion and function ...
(Date:3/28/2017)... ... March 28, 2017 , ... Alert Sentry Group LLC., a leader in the ... Systems), the iSAFE and the iSAFE Plus. These iSAFE products are the most affordable ... the iSAFE and iSAFE Plus offer direct GPS Location and two-way calling with the ...
(Date:3/28/2017)... ... March 28, 2017 , ... The Radiology Business Management ... begun to serve as its new executive director. Mr. Still was selected through a ... , “Bob, as he is known to our members, has been a part ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... , March 28, 2017  Market leading ... announced a partnership with premium news content provider ... companies to extract key insights from Dow Jones ... technology. The Linguamatics I2E platform is ... global pharmaceutical companies. The Linguamatics-Dow Jones partnership helps ...
(Date:3/28/2017)... , March 28, 2017  CASI Pharmaceuticals, ... innovative therapeutics addressing cancer and other unmet medical ... American Association for Cancer Research annual meeting.  The ... is entitled "Evaluation of ENMD-2076 in Combination ... the second poster to be presented on April ...
(Date:3/28/2017)... , March 28, 2017 Elysium ... with Cambridge academic ...   The Milner Therapeutics Institute today announces Elysium ... Health has committed significant investment for collaborative projects with academic ... four years. This is the first major research investment outside ...
Breaking Medicine Technology: